Prosecution Insights
Last updated: October 02, 2026
Application No. 18/928,484

SYSTEMS AND METHODS FOR GUIDING A PATIENT DURING IMAGING PROCEDURES

Non-Final OA §102§103
Filed
Oct 28, 2024
Priority
Sep 23, 2020 — provisional 63/082,248 +2 more
Examiner
KAO, CHIH CHENG G
Art Unit
Tech Center
Assignee
Hologic Inc.
OA Round
1 (Non-Final)
83%
Grant Probability
Favorable
1-2
OA Rounds
7m
Est. Remaining
92%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allowance Rate
995 granted / 1204 resolved
+22.6% vs TC avg
Moderate +10% lift
Without
With
+9.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
27 currently pending
Career history
1228
Total Applications
across all art units

Statute-Specific Performance

§101
3.7%
-36.3% vs TC avg
§103
46.6%
+6.6% vs TC avg
§102
21.3%
-18.7% vs TC avg
§112
20.6%
-19.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1204 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 21-25, 28-35, and 38-40 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Nagai et al. (JP 2013-066784 A; hereinafter Nagai). Regarding claim 21, Nagai discloses a method of guiding patient action during a procedure (abstract) with a breast imaging system (fig. 1), the method comprising: immobilizing a breast of a patient (with 14) at the breast imaging system (fig. 1); detecting a first condition of a tube head of the breast imaging system (in order to determine X-ray main exposure time in S23); based on the detected first condition of the tube head, providing a first guidance signal (at display 35 with a 100% progress bar when starting exposure) to the patient (P); detecting a second condition of the tube head (in order to determine X-ray main exposure time at completion in S24), wherein the second condition (completion) is different than the first condition (start); and based on the detected second condition of the tube head, providing a second guidance signal to the patient (0% progress bar), wherein the second guidance signal (0% progress bar) is different than the first guidance signal (100% progress bar). Regarding claim 31, Nagai discloses a breast imaging system (fig. 1) comprising: a gantry (21); an immobilization system (14) movably secured to the gantry, the immobilization system including a breast support platform (16/17) and an immobilization arm (with 14) movable relative to the breast support platform (16/17); a tube head having an x-ray source (11) rotatably connected to the gantry (21); and a patient guidance module comprising an output device (35) for sending a first guidance signal and a different second guidance signal to a patient when a breast of the patient is immobilized by the immobilization system, wherein the first guidance signal is based on a first condition of the tube head and the second guidance signal is based on a second condition of the tube head, the second condition different than the first condition (at display 35 with progress bar relative to pulse width of X-ray from the tube head). Regarding claims 22 and 32, Nagai discloses wherein the first condition of the tube head and the second condition of the tube head (11) are associated with imaging modes of the breast imaging system (fig. 1). Regarding claims 23 and 33, Nagai discloses wherein the imaging modes include a tomosynthesis mode and a mammogram mode (pars. 22 and 24). Regarding claims 24 and 34-35, Nagai discloses wherein the imaging modes include at least one of a tomosynthesis mode, a mammogram mode, and a wide-angle tomosynthesis mode (pars. 22 and 24). Regarding claim 25, Nagai discloses wherein the imaging modes are performed during a single breast (of P) immobilization (with 14). Regarding claims 28 and 38, Nagai discloses wherein at least one of the first and second guidance signals include an audible sound (via 49 with voice or electronic sounds). Regarding claims 29 and 39, Nagai discloses wherein at least one of the first and second guidance signals include an emitted light (to show the progress bar on 35). Regarding claims 30 and 40, Nagai discloses wherein the first and second guidance signals include an audible sound (via 49 with voice or electronic sounds) and an emitted light (to show the progress bar on 35). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 26-27 and 36-37 is/are rejected under 35 U.S.C. 103 as being unpatentable over Nagai as applied to claims 21 and 31 above, and further in view of Helmreich et al. (US 2009/0080186; hereinafter Helmreich). Regarding claims 26 and 36, Nagai discloses claims 21 and 31 above. However, Nagai fails to disclose wherein the first and second guidance signals are configured to guide breathing for the patient. Helmreich teaches wherein the first and second guidance signals are configured to guide breathing for the patient (pars. 18 and 50). It would have been obvious, to one having ordinary skill in the art before the effective filing date of the invention, to modify Nagai with the teaching of Helmreich, since one would have been motivated to make such a modification for comfort and proper positioning (Helmreich: par. 4). Regarding claims 27 and 37, Helmreich teaches wherein guiding breathing for the patient includes instructions to track inhalation to gradually (par. 23) increasing light levels (par. 18: by increasing colored light levels relative to other colors) and to track exhalation to gradually decreasing light levels (par. 18: by decreasing colored light levels relative to other colors). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Chih-Cheng Kao whose telephone number is (571)272-2492. The examiner can normally be reached M-F 9-5. Examiner interviews are available via telephone and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Makiya can be reached at (571) 272-2273. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Chih-Cheng Kao/Primary Examiner, Art Unit 2884
Read full office action

Prosecution Timeline

Oct 28, 2024
Application Filed
Sep 10, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12745973
PCCT APPARATUS AND CONTROL METHOD OF THE SAME
1y 9m to grant Granted Sep 29, 2026
Patent 12749324
System and Method for Authentication of Antique Porcelain
1y 8m to grant Granted Sep 29, 2026
Patent 12742894
Wavelength-Shifting Sheet-Coupled Scintillation Detectors
1y 7m to grant Granted Sep 22, 2026
Patent 12733895
RADIOGRAPHIC SYSTEM AND METHOD FOR CONTROLLING THE SAME
3y 5m to grant Granted Sep 15, 2026
Patent 12733086
CONTROLLING X-RAY TUBE ELECTRON BEAM OPTICS DURING KVP SWITCHING
1y 2m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
83%
Grant Probability
92%
With Interview (+9.5%)
2y 6m (~7m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1204 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month